ClearPoint Neuro Inc vs Tencent Music Entertainment Group - ADR — how do they compare? ClearPoint Neuro Inc trades at $15.17 (market cap $454.21M), while Tencent Music Entertainment Group - ADR trades at $8.38 (market cap $16.09B). The key difference: Tencent Music Entertainment Group - ADR is far larger — about 35.4× ClearPoint Neuro Inc's market cap, and Tencent Music Entertainment Group - ADR pays a 2.75% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CLPT | TME | |
|---|---|---|
Market Cap | $454.21M | $16.09B |
Sector | Health | Media |
52-Week High | $29.60 | $26.36 |
52-Week Low | $8.66 | $8.16 |
Enterprise Value | $488.79M | $14.05B |
Dividend Yield | — | 2.75% |
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $15.20, up 4.32% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue growth but missed earnings estimates, with a net income margin of -81.76%. Recent news highlights regulatory progress with partners and expansion into focused ultrasound technology.
The outlook remains speculative with high growth potential in neurotherapy markets, but significant execution and profitability risks persist. Analyst consensus is unanimously bullish, though sustained losses and cash burn require careful monitoring for long-term investors.
Tencent Music Entertainment (TME) is trading at $8.38, down 15.35% amid mixed Q2 2026 results that showed revenue growth but profit beat expectations. The stock faces bearish technical signals with oversold RSI conditions, while fundamentals remain strong with 33.6% net margin and attractive valuation at 10.29 P/E. Recent news highlights slowing operational growth and competitive pressures, though institutional activity shows mixed positioning with some funds increasing stakes while others reduce exposure.
TME presents a value opportunity with solid profitability and cash flow generation, but near-term headwinds include intensifying competition, AI-related copyright challenges, and slowing user growth. Analyst consensus leans neutral with 45.8% buy ratings, suggesting cautious optimism for long-term investors willing to navigate current volatility.
Trailing returns across standard periods
Latest headlines on both assets
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →